BULLFROG AI HOLDINGS, INC.

BFRG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Operating Activities
Net Income $-6.5M $-7.0M $-5.4M $-2.8M $-585.8K
Depreciation & Amortization
Depreciation $1.7K $1.7K $1.7K $1.0K
Amortization
Stock-Based Compensation $1.0M $943.6K $631.5K $340.2K $99.0K
Net Cash from Operating Activities $-5.5M $-5.6M $-6.0M $-910.9K $-382.4K
Investing Activities
Capital Expenditures $8.7K
Business Acquisitions
Net Cash from Investing Activities $-8.7K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $2.4M $8.4M $8.6M $967.3K $387.4K
Net Change in Cash $-3.1M $2.8M $2.6M $47.7K $5.0K
Free Cash Flow $-919.6K